Are deficits of arachidonic and docosahexaenoic acids responsible for the neural and vascular complications of preterm babies?

American Journal of Clinical Nutrition

Volumn 66, Issue 4 SUPPL., 1997, Pages

  Crawford, Michael A ^a   Costeloe, Kate ^b   Ghebremeskel, Kebreab ^b   Phylactos, Andreas ^b   Skirvin, Louise ^b   Stacey, Fiona ^b  

^a LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

^b NONE

Author keywords

Antioxidant enzymes; Antioxidant vitamins; Arachidonic acid; Cardiovascular disease; Cerebral palsy; Cerebrovascular disease; Docosahexaenoic acid; Essential fatty acids; Fetus; Intraventricular hemorrhage; Maternal nutrition; Neurodevelopmental disorder; Nutritional pharmacology; Periventricular leucomalacia; Preterm infants

Indexed keywords

ANTIOXIDANT; ARACHIDONIC ACID; COPPER ZINC SUPEROXIDE DISMUTASE; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; LINOLEIC ACID; LINOLENIC ACID;

BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; CEREBRAL PALSY; CONFERENCE PAPER; DIET THERAPY; ENDOTHELIUM; LIPID METABOLISM; MATERNAL NUTRITION; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGICAL COMPLICATION; PREMATURITY;

EID: 0030856729     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/66.4.1032S     Document Type: Conference Paper

References (85)

1. Levine M. Cerebral ultrasound and neurological impairment: telling the future. Arch Dis Child 1990;65:469-71.
2. Anderson RE, Made MB. Lipids of ocular tissues: VII. The effects of essential fatty acid deficiency on the phospholipids of the photoreceptor membranes of rat retina. Arch Biochem Biophys 1972;151:270-6.
3. Crawford MA, Casperd NM, Sinclair AJ. The long chain metabolites of linoleic and linolenic acids in liver and brain in herbivores and carnivores. Comp Biochem Physiol 1976;54B:395-401.
4. +)-ATPase activity during essential fatty acid deficiency. J Neurochem 1974;22:15-8.
5. Budowski P, Leighfield MJ, Crawford MA. Nutritional encephalomalacia in the chick: an exposure of the vulnerable period for cerebellar development and the possible need for both ω6 and ω3 fatty acids. Br J Nutr 1987;58:511-20.
6. Bazan NG. Supply of n-3 polyunsaturated fatty acids and their significance in the central nervous system. In: Wurtman RJ, Wurtman JJ, eds. Nutrition and the brain. New York: Raven Press, 1990:1-24.
7. Sprecher H. Interconversions between 20-and 22-carbon n-3 and n-6 fatty acids via 4-desaturase independant pathways. In: Sinclair AJ, Gibson R, eds. IIIrd International Congress on Essential Fatty Acids and Eicosanoids, Adelaide. Champaign, IL: American Oil Chemists' Society, 1993:18-22.
8. Sinclair AJ. Long chain polyunsaturated FAs in the mammalian brain. Proc Nutr Soc 1975;34:287-91.
9. Kühn DC, Crawford MA. Placental essential fatty acid transport and prostaglandin synthesis. Prog Lipid Res 1986;25:345-53.
10. Olegard R, Svennerholm L. Fatty acid composition of plasma and red cell phosphoglycerides in full term infants and their mothers. Acta Paediatr Scand 1970;59:637-47.
11. Crawford MA, Hassam AG, Williams G, Whitehouse WL. Essential fatty acid and fetal brain growth. Lancet 1976;1:452-3.
12. Chapman D, Benga G. Biomembrane fluidity-studies of model and natural membranes. In: Chapman D, ed. Biological membranes. Vol 5. London: Academic Press, 1984:1-56.
13. Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976;263:663-5.
14. Samuelsson B. Leukotrienes and other lipoxygenase products. Prog Lipid Res 1986;25:13-8.
15. British Nutrition Foundation. Functions of unsaturated fatty acids. In: Task Force on Unsaturated Fatty Acids. Nutritional and physiological significance. London: Chapman & Hall, 1992:48-62.
16. Holman RT, Johnson SB, Ogburn PL. Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation. Proc Natl Acad Sci U S A 1991;88:4835-9.
17. Al MDM, Houwelingen AC, Kester ADM, Hasaart THM, De-Jong AET, Hornstra G. Maternal essential fatty acid patterns during normal pregnancy and relationship to neonatal essential fatty acid status. Br J Nutr 1995;74:55-68.
18. Rush D, Alvir JM, Kenny DA, Johnson SS, Horwitz DG. The National WIC Evaluation: evaluation of the Special Supplemental Food Program for Women, Infants and Children. III. Historical study of pregnancy outcomes. Am J Clin Nutr 1988;48(suppl):412-28.
19. Spatling L, Spatling G. Magnesium supplementation in pregnancy: a double blind study. Br J Obstet Gynaecol 1988;95:120-5.
20. Villar J, Rivera J. Nutritional supplementation during two consecutive pregnancies and the interim lactation period: effect on birthweight. Pediatrics 1988;81:51-7.
21. Doyle W, Crawford MA, Wynn AH, Wynn SW. The association between maternal diet and birth dimensions. J Nutr Med 1990;1:9-17.
22. Wynn AHA, Crawford MA, Doyle W, Wynn SW. Nutrition of women in anticipation of pregnancy. Nutr Health 1991;7:69-88.
23. Ongari MA, Ritter JM, Orchard MA, Waddell KA, Blair IA, Lewis PJ. Correlation of prostacyclin synthesis by human umbilical artery with status of essential fatty acid. Am J Obstet Gynecol 1984;149:455-60.
24. Crawford MA, Doyle W, Drury PJ, Lennon A, Costeloe K, Leighfield M. n-6 and n-3 fatty acids during early human development. J Intern Med 1989;225(suppl 1):159-69.
25. Crawford MA, Costeloe K, Doyle W, Leighfield MJ, Lennon EA, Meadows N. Potential diagnostic value of the umbilical artery as a definition of neural fatty acid status of the fetus during its growth. Biochem Soc Trans 1990;18:761-6.
26. Leaf AA, Leighfield MJ, Costeloe KL, Crawford MA. Factors affecting long-chain polyunsaturated fatty acid composition of plasma choline phosphoglycerides in preterm infants. J Pediatr Gastroenterol Nutr 1992;14:300-8.
27. Leaf AA, Leighfield MJ, Costeloe KL, Crawford MA. Long chain polyunsaturated fatty acids and fetal growth. Early Hum Dev 1992;30:183-91.
28. Carlson SE, Rhodes PG, Ferguson MG. Docosahexaenoic acid status of preterm infants at birth and following feeding with human milk or formula. Am J Clin Nutr 1986;44:798-804.
29. Ghebremeskel K, Leighfield M, Leaf A, Costeloe K, Crawford MA. Fatty acid composition of plasma and red cell phospholipids of preterm babies fed on breast milk and formulae. Eur J Pediatr 1995;154:46-52.
30. Farquharson J, Cockbum F, Patrick AW, Jamieson E, Logan RW. Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet 1993;40:810-3.
31. Birch EE, Birch D, Hoffman D, et al. Dietary essential fatty acid supply and visual acuity development. Invest Ophthalmol Vis Sci 1993;30:33-8.
32. Carlson SE, Werkman SH, Rhodes, Tolley EA. Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation. Am J Clin Nutr 1993;58:35-42.
33. Makrides M, Neuman M, Simmer K, Pater J, Gibson R. Are long chain polyunsaturated fatty acids essential nutrients in infancy? Lancet 1995;345:1463-8.
34. Lucas A, Morley R, Cole TJ, Lister G, Leeson-Payne C. Breast milk and subsequent intelligence quotient in children born preterm. Lancet 1992;339:261-4.
35. Lanting CI, Fidler V, Huisman BCL, Boersma ER. Neurological differences between 9 year old children fed breast-milk or formula as babies. Lancet 1994;344:1319-22.
36. Staub E, Winkler A, Peters J, Kempski O, Kachel V, Baethmann A. Swelling, acidosis and irreversible damage of glial cells from exposure to arachidonic acid in vitro. J Cereb Blood Flow Metab 1994;14:1030-9.
37. Sakashita N, Anda T, Yonehara T, et al. Role of superoxide dismutase and nitric oxide on the interaction between brain and systemic circulation during ischaemia. Biochim Biophys Acta 1994;1227:67-73.
38. Connor WE, Neuringer M, Reisbick S. Essential fatty acids: the importance of n-3 fatty acids in the retina and brain. Nutr Rev 1992;50:21-9.
39. Dieter P. Arachidonic acid and eicosanoid release (mononuclear phagocytes). J Immunol Methods 1994;174:223-30.
40. Li BY, Birdwell C, Whelan J. Antithetic relationship of dietary arachidonic acid and eicosapentaenoic acid on eicosanoid production in vivo. J Lipid Res 1994;35:1869-77.
41. Rea D, Porter J, Beechey-Newman N, Sumar N, Bennet D, Hermon-Taylor J. Type 1 phospholipase A2 propetide in acute lung injury. Lancet 1994;344:1472-3.
42. Chiswick ML, Gladman G, Sinha S, Toner N, Davies J. Vitamin E supplementation and periventricular hemorrhage in the newborn. Am J Clin Nutr 1991;53(suppl):370S-2S.
43. Sullivan JL. Iron, plasma antioxidants, and the 'oxygen radical disease of prematurity.' Am J Dis Child 1988;142:1341-4.
44. Shenai JP, Kennedy KA, Chytil F, Stahlman MT. Clinical trail of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr 1987;111:269-77.
45. Esterbauer H, Wag G, Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull 1993;49:566-76.
46. Ghebremeskel K, Burns L, Burden TJ, et al. Vitamin A and related essential nutrients in cord blood: relationship with anthropometric measurements at birth. Early Hum Dev 1994;39:177-88.
47. Fujimoto S, Yamaguchi N, Togari H, Wada Y, Yokochi K. Cerebral palsy of cystic periventricular leukomalacia in low-birthweight infants. Acta Paediatr 1994;83:397-401.
48. Phylactos AC, Leaf AA, Costeloe K, Crawford MA. Erythrocyte cupric/zinc superoxide dismutase exhibits reduced activity in preterm and low birthweight infants at birth. Acta Paediatr 1995;84:1421-5.
49. Kelly FJ. Free radical disorders of preterm infants. Br Med Bull 1993;49:668-78.
50. Hittner HM, Godio LB, Speer ME, et al. Retrolental fibroplasia: further clinical evidence and ultrastructural support for efficiency of vitamin E in the preterm infant. Pediatrics 1983;71:423-32.
51. Gallo JE, Jacobson L, Broberger U. Perinatal factors associated with retinopathy of prematurity. Acta Paediatr 1993;82:829-34.
52. Author AP, Frank L, Roberts RJ. Developmental characteristics of pulmonary superoxide dismutase: a relationship to idiopathic respiratory distress syndrome. Pediatr Res 1976;10:154-8.
53. Gobel W, Richard G. Retinopathy of prematurity - current diagnosis and management. Eur J Pediatr 1993;152:286-90.
54. FAO/WHO. Role of dietary fats and oils in human nutrition. Report of an FAO/WHO Expert Consultation. Rome: FAO, 1987.
55. FAO/WHO. Fats and oils in human nutrition. Report of a joint expert consultation. Rome: FAO, 1995. (Food and nutrition paper 57.)
56. Marmot MGM, Shipley MJ, Rose G. Inequalities of death - specific explanations of a general pattern? Lancet 1984;1:1003-6.
57. Black D, Morris JN, Smith C, Townsend P. The black report. London: Her Majesty's Stationery Office, 1982.
58. Barker DJP, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993;341:938-41.
59. Sinclair HM. Deficiency of essential fatty acids et cetera. Lancet 1956;1:381.
60. Vergroessen A, Crawford MA, eds. The role of dietary fats in human nutrition. London: Academic Press, 1989.
61. Grundy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res 1990;31:1149-72.
62. Dyerberg Stofferson E, Bang HO, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis. Lancet 1978;2:117-9.
63. Burr MI, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on Death and Myocardial Re-infarction Trial (DART). Lancet 1989;334:7577-661.
64. Lorgil M, Renaud S, Mamelle N, et al. Mediteranean, alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454-9.
65. British Nutrition Foundation. Unsaturated fatty acids and atherosclerosis. In: Task Force on Unsaturated Fatty Acids. Nutritional and physiological significance. London: Chapman & Hall, 1992:87-91.
66. British Nutrition Foundation. Unsaturated fatty acids: thrombogenesis and fibrinolysis. In: Task Force on Unsaturated Fatty Acids. Nutritional and physiological significance. London: Chapman & Hall, 1992:92-111.
67. Cunnane SC. Childhood origins of lifestyle-related risk factors for coronary heart disease in adulthood. Nutr Health 1993;9:107-16.
68. Louw ME, Du Plessis JP, Van den Berg AS. Intercorrelation study of dietary and biochemical data from school children in the Pretoria area. S Afr Med J 1969;43:1516-8.
69. Crawford MA, Hassam AJ, Rivers JPW. Vulnerability of the artery during growth. Postgrad Med J 1978;54:149-53.
70. Lauer RM, Clarke WR, Rames LK. Blood pressure and its significance in childhood. Postgrad Med J 1978;54:206-10.
71. Newman WP, Freedman DS, Voors AW, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogolusa Heart Study. N Engl J Med 1986;314:138-44.
72. Asmussen I. Arterial changes in infants of smoking mothers. Postgrad Med J 1978;54:200-4.
73. Osborne G. Stages in development of coronary artery disease observed from 1,500 young subjects. Paris: Editions du Centre National de la Recherhe Scientifique, 1967.
74. Personen E, Norio R, Hirvonen J, et al. Intimal thickening in the coronary arteries of infants and children as an indicator of risk factors for coronary heart disease. Eur Heart J 1990;11(suppl E):53-60.
75. Enos WF, Holmes RH. Coronary disease among United States soldiers killed in action in Korea. JAMA 1953;152:1090-3.
76. Weintraub MS, Zechner R, Brown A, Eisenberg S, Breslow JL. Dietary polyunsaturated fats of the ω-6 and ω-3 series reduce postprandial lipoprotein levels. J Clin Invest 1988;82:1884-93.
77. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans, a critical review. J Lipid Res 1989;30:785-807.
78. Wong S, Nestel PJ. Eicosapentaenoic acid inhibits the secretion of triacylglycerol and of apoprotein and the binding of LDL in HepG2 cells. Atherosclerosis 1987;64:139-46.
79. Van Biervliet JP, Vinaimont N, Vercamst R, Rosseneu M. Serum cholesterol, cholesteryl ester and high density lipoprotein development in new born infants: response to formulas supplemented with cholesterol and gamma-linolenic acid. J Pediatr 1992;120:S101-8.
80. Van Biervliet J-P, Michiels G, Rosseneu M. Quantification of lipoprotein (a) in dried blood spots and screening for above normal lipoprotein (a) concentrations in newborns. Clin Chem 1991;37:706-8.
81. Yang EK, Radinksa A, Winder BS, Dannenberg AJ. Dietary lipids coinduce xenobiotic metabolizing enzymes in rat liver. Biochim Biophys Acta 1993;1168:52-8.
82. Clarke SD, Jump DB. Regulation of gene transcription by polyunsaturated fatty acids. Prog Lipid Res 1993;32:139-49.
83. Sosenko IRS. Do polyunsaturated fatty acids protect against oxidant-induced lung damage? J Nutr 1995;125:1652S-6S.
84. Budowski P. The omega-3 fatty acid peroxidation paradox. Redox Report 1996;2:75-7.
85. Saugsted OD. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr 1996;85:1-4.